cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Anika Therapeutics Inc
9 own
16 watching
Current Price
$16.02
$0.44
(2.82%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
364.44M
52-Week High
52-Week High
29.12000
52-Week Low
52-Week Low
15.40000
Average Volume
Average Volume
0.06M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
30.56
iconMarket Capitalization364.44M
icon52-Week High29.12000
icon52-Week Low15.40000
iconAverage Volume0.06M
iconDividend Yield--
iconP/E Ratio30.56
What does the Anika Therapeutics Inc do?
Anika Therapeutics, Inc., together with its subsidiaries, provides orthopedic medicines for patients with degenerative orthopedic diseases and traumatic conditions in the United States and internationally. The company develops, manufactures, and commercializes therapeutic products based on its proprietary hyaluronic acid (HA) technology. Its orthobiologics products comprise ORTHOVISC, ORTHOVISC mini, MONOVISC, and CINGAL for the treatment of osteoarthritis of the knee; HYALOFAST, a biodegradable support for human bone marrow mesenchymal stem cells used for cartilage regeneration and as an adjunct for microfracture surgery; HYALONECT, a woven gauze used as a bone graft wrap; HYALOSS used to mix blood/bone grafts to form a paste for bone regeneration; and HYALOGLIDE, an ACP gel used in tenolysis treatment. The company's dermal products include wound care products that comprise HYALOMATRIX and HYALOFILL for the treatment of complex wounds, such as burns and ulcers, and for use in connection with the regeneration of skin; and ELEVESS, an aesthetic dermatology product. Its surgical products comprise HYALOBARRIER, a post-operative adhesion barrier for use in the abdomino-pelvic area; INCERT, a HA product used for the prevention of post-surgical spinal adhesions; MEROGEL, a woven fleece nasal packing; and MEROGEL INJECTABLE, a viscous hydrogel. The company also offers ophthalmic products, including injectable HA products that are used as viscoelastic agents in ophthalmic surgical procedures, such as cataract extraction and intraocular lens implantation; and veterinary products, which include HYVISC, an injectable HA product for the treatment of joint dysfunction in horses. Anika Therapeutics, Inc. was founded in 1983 and is headquartered in Bedford, Massachusetts.
Read More
How much money does Anika Therapeutics Inc make?
News & Events about Anika Therapeutics Inc.
Globe Newswire
1 year ago
BEDFORD, Mass., April 12, 2023 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today announced that management will participate in the 22nd Annual Needham Virtual Healthcare Conference on Thursday, April 20, 2023. ...
Globe Newswire
1 year ago
Tactoset cleared by the FDA to be combined with autologous bone marrow aspirate, a core element for regenerative healing Anika reaches agreement to distribute the Marrow Cellution Bone Marrow Aspiration Needle in the U.S. and commences launch Launches enhanced Tactoset cannulas, which improve ...
Globe Newswire
1 year ago
BEDFORD, Mass., March 27, 2023 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK) (Anika or the Company), a global joint preservation company in early intervention orthopedics, today announced that it has filed its preliminary proxy materials with the Securities and Exchange Commission (SEC...
Accesswire
1 year ago
NEW YORK, NY / ACCESSWIRE / March 20, 2023 / Sidoti & Company, LLC has released the presentation schedule and weblinks for its two-day March Small-Cap Conference taking place Wednesday and Thursday, March 22-23, 2023. The links can also be found at www.sidoticonference.com/events. Virtual...
Zolmax
1 year ago
Barrington Research cut shares of Anika Therapeutics (NASDAQ:ANIK Get Rating) from an outperform rating to a market perform rating in a research note released on Tuesday, Marketbeat reports. Barrington Research also issued estimates for Anika Therapeutics Q1 2024 earnings at ($0.25) EPS, Q2 2024 ...
Frequently Asked Questions
Frequently Asked Questions
What is Anika Therapeutics Inc share price today?
plus_minus_icon
Can Indians buy Anika Therapeutics Inc shares?
plus_minus_icon
How can I buy Anika Therapeutics Inc shares from India?
plus_minus_icon
Can Fractional shares of Anika Therapeutics Inc be purchased?
plus_minus_icon
What are the documents required to start investing in Anika Therapeutics Inc stocks?
plus_minus_icon
What is today’s traded volume of Anika Therapeutics Inc?
plus_minus_icon
What is today’s market capitalisation of Anika Therapeutics Inc?
plus_minus_icon
What is the 52-Week High and Low Range of Anika Therapeutics Inc?
plus_minus_icon
What percentage is Anika Therapeutics Inc down from its 52-Week High?
plus_minus_icon
What percentage is Anika Therapeutics Inc up from its 52-Week Low?
plus_minus_icon
Current Price
$16.02
$0.44
(2.82%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Related Stocks
Stryker Corporation
Stryker Corporation
$368.47
$5.67 (1.56 %)
MiMedx Group, Inc.
MiMedx Group, Inc.
$8.80
$0.20 (2.26 %)
ORTHOFIX MEDICAL INC
ORTHOFIX MEDICAL INC
$17.94
$0.43 (2.46 %)
Ligand Pharmaceuticals Incorporated
Ligand Pharmaceuticals Incorporated
$110.28
$1.73 (1.59 %)
Sign up and dive into a whole new world of investing.
Join over 500,000 who have signed up and are using Stockal successfully already.
Related Stocks
Stryker Corporation
Stryker Corporation
$368.47
$5.67 (1.56 %)
MiMedx Group, Inc.
MiMedx Group, Inc.
$8.80
$0.20 (2.26 %)
ORTHOFIX MEDICAL INC
ORTHOFIX MEDICAL INC
$17.94
$0.43 (2.46 %)
Ligand Pharmaceuticals Incorporated
Ligand Pharmaceuticals Incorporated
$110.28
$1.73 (1.59 %)
Sign up and dive into a whole new world of investing.
Join over 500,000 who have signed up and are using Stockal successfully already.

              Borderless Softtech Pvt Ltd ("BSPL") licenses and offers the Stockal Platform to subscribers and users who are based in India and wish to make global transactions. Such subscribers and users may be offered annual or monthly subscription plans by BSPL and in such cases, BSPL acts as their service provider.

              Borderless Investing Inc., (“Borderless Investing”), the owner of the Stockal Platform, is not a broker-dealer nor an investment advisor and through its affiliate stockbroker Stockal Securities Pvt. Ltd., (SEBI INZ000301236), acting as the introducing entity has entered into a clearing agreement with DriveWealth LLC., to offer U.S. equities on the Stockal Platform. The Stockal Platform enables investments in a diverse set of global assets from a single account from anywhere in the world. As such, Borderless Investing makes no warranties or representations, express or implied, on products and services offered through its website/platform. It accepts no liability for any damages or losses, however, caused in connection with the use of related services.

              All investments involve risk and returns will fluctuate, are subject to market volatility and may cause losses. The material on this website/platform is provided solely for informational and educational purposes and shall not in any manner be considered a recommendation or endorsement of any strategy or investment, nor an offer to sell or a solicitation of an offer to buy securities, products or services nor advice. Borderless Investing makes no guarantee as to the currency, accuracy, or quality of information published and/or archived on this website/platform, nor will Borderless Investing accept any responsibility for other organizations, businesses, and private persons that provide information on this website/platform. All information on this website/platform regarding products and services provided by Borderless Investing is subject to change without notice. Reasonable efforts are taken to ensure the accuracy and integrity of all information provided here, but Borderless Investing is not responsible for misprints, out of date information, or errors. Any investment decision and/or strategy that investors make or employ, whether or not such decision or strategy derives from or relies upon material accessed or provided through this website/platform, is undertaken at the investor’s sole discretion and risk. Before making any investment decisions, investors should consult additional sources of information and/or their legal or tax advisor. PLEASE READ THIS FULL DISCLOSURE CAREFULLY BEFORE USING THIS SERVICE. BY USING THE SERVICE OR CLICKING AGREE YOU ARE AGREEING TO BE BOUND BY THESE DISCLOSURES AND ALL TERMS AND CONDITIONS ON THIS WEBSITE/PLATFORM.

              *DriveWealth LLC., a member of the Securities Investor Protection Corporation (SIPC), will serve as the custodian for your securities account. In the event that DriveWealth LLC., fails and is placed in liquidation under the Securities Investor Protection Act, securities in your brokerage account may be protected up to $500,000. For details, please see www.sipc.org.

              All brands and logos used on this website are the property of their respective owners.

              Get Started with as little as $1.00